Trametinib: Potential therapeutic game-changer for Alzheimer’s disease

FHS
October 4, 2023
10:05 am

Researchers developed the ATRIVIEW® platform to screen for molecules that promote differentiation neural stem cells (NSCs).

2seventy bio, Bristol Myers stop late-stage Abecma study in multiple myeloma due to recruitment challenges

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 26, 2024

Pα+ Psychedelic Bulletin #163: Tempering Excitement Around Recent Raises; Compass Shares Cut of Open-Label PTSD Data; Other News – Psychedelic Alpha

Featured content in this Issue: Tempering Excitement Around Recent Raises Compass Shares Cut of Open-Label PTSD Data Other Stories: We bring you up to speed

May 17, 2024

Opportunistic Infections Put a Damper on Belatacept After Lung Transplant

HONOLULU — Lung transplant clinicians had a rocky start using belatacept (Nulojix) for immunosuppression at one large-volume center, though they maintained that the agent could

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.